• Annexin V Binding and Endothelial Thrombin

  2026-09-01

  The 1994 Biochemical Journal study moved annexin V analysis from model phospholipid vesicles to cultured human endothelial cells, quantifying both cell-surface binding and inhibition of coagulation reactions. Its findings show that recombinant annexin V binds quiescent and stimulated HUVEC with similar capacity while suppressing factor Xa and thrombin generation at nanomolar concentrations, providing a mechanistic framework for interpreting phosphatidylserine-dependent assays.

• Lopinavir: From HIV Potency to Repurposing Strategy

  2026-09-01

  Lopinavir (ABT-378) offers a useful translational case study: exceptionally strong HIV protease inhibition, resilience against selected resistance mutations, and a cell-culture signal against MERS-CoV. This article connects mechanism, assay design, repurposing evidence, pharmacokinetic interpretation, and decision points for HIV drug resistance studies and broader antiviral research.

• Hesperadin: Aurora B Kinase Inhibitor Workflows

  2026-08-31

  Hesperadin provides a practical way to connect Aurora B activity with mitotic phenotypes, from reduced histone H3 Ser10 phosphorylation to chromosome missegregation and polyploidization. This guide presents assay-ready workflows, controls, and troubleshooting strategies while clarifying how Aurora B perturbation complements studies of Plk1-regulated checkpoint disassembly.

• Palonosetron and CINV Prevention: Evidence and Limits

  2026-08-30

  Ruhlmann and Herrstedt’s review explains why palonosetron became a distinctive 5-HT3 receptor antagonist: it combines prolonged exposure and high receptor affinity with allosteric binding and positive cooperativity. The review’s practical contribution is to place these pharmacologic properties alongside clinical evidence for acute and delayed chemotherapy-induced nausea and vomiting, while emphasizing that combination therapy and endpoint selection determine real-world benefit.

• Linoleic Acid: Practical Assay Setup and QC

  2026-08-29

  Linoleic Acid (SKU C3108; C18:2(9Z,12Z)) provides a practical research reagent for modeling lipid-associated oxidative stress, membrane behavior, epithelial migration, and essential fatty acid deficiency. It is appropriate for controlled in vitro and animal-study workflows, but its water insolubility, oxidation sensitivity, and undefined model-specific dosing require fresh preparation, vehicle controls, and pilot optimization.

• Vemurafenib Workflow for BRAF-Mutant Melanoma

  2026-08-29

  Vemurafenib, also known as PLX4032, enables genotype-aware studies of BRAF-driven signaling, melanoma cell proliferation inhibition, and acquired drug resistance. This practical workflow connects dose-response testing with time-resolved phospho-signaling and ARID1A-focused multi-omics to improve assay interpretation.

• Tin Mesoporphyrin IX: HO Assay Workflow

  2026-08-28

  Tin Mesoporphyrin IX (chloride) provides a nanomolar pharmacological control for dissecting heme oxygenase biology, from biochemical activity assays to ROS-linked viral phenotypes. This workflow emphasizes concentration design, orthogonal readouts, and troubleshooting for metabolic disease research and mechanistic HBV studies.

• Bafilomycin A1 as a Mitophagy Flux Probe

  2026-08-28

  Bafilomycin A1 is more than a V-ATPase inhibitor: it can define the lysosomal boundary of pathogen-driven mitophagy assays. This guide connects reversible proton-pump inhibition with the BipD–IMMT mechanism and practical experimental decisions.

• Mitochondrial Repair in Diabetic Periodontitis

  2026-08-27

  The reference study develops a hierarchically targeted, ROS-responsive hydrogel that delivers MitoQ-loaded nanoparticles to inflammatory M1 macrophages and repairs their damaged mitochondria. In diabetic periodontitis models, this design reduced inflammasome-associated inflammation, protected periodontal tissue, and promoted alveolar bone regeneration, while also illustrating how local biomaterial delivery can address a self-amplifying ROS mechanism.

• Bergenin Targets γδT17 Cells in Psoriasis

  2026-08-27

  A 2026 Phytomedicine study identifies bergenin as a plant-derived PPARγ agonist that suppresses pathogenic γδT17 cells in psoriasis. Its central mechanistic advance is the connection of PPARγ activation to K248-linked PROX1 ubiquitination, reduced fatty acid oxidation, diminished IL17A promoter acetylation, and lower IL-17A production.

• Dihydroethidium for Superoxide Assays

  2026-08-26

  Dihydroethidium, also called hydroethidine, provides a practical live-cell readout for relative intracellular superoxide changes in oxidative stress, apoptosis, and cardiotoxicity models. This guide connects DHE assay design with the GOT2-centered findings of a recent doxorubicin cardiotoxicity study, emphasizing controls, workflow decisions, and troubleshooting.

• InstaBlue Protein Stain Solution: Practical Protocol

  2026-08-26

  InstaBlue Protein Stain Solution provides rapid Coomassie-based visualization of protein bands in polyacrylamide gels without fixation, washing, or destaining. It is suited to routine protein electrophoresis analysis and downstream mass spectrometry workflows, but staining intensity should not be treated as an absolute protein quantification assay without separate calibration.

• Trichostatin A, ERK/FoxO3a, and Acute Pancreatitis

  2026-08-25

  This 2026 study identifies the ERK/FoxO3a axis as a candidate regulator of impaired autophagic flux in acute pancreatitis and examines how trichostatin A may modify this pathway. Using network pharmacology, AR42J-cell experiments, pharmacological perturbation, and a rat model, the authors link reduced ERK phosphorylation with improved autophagy-related, inflammatory, mitochondrial, and histological outcomes.

• Solanesol (B8776): Handling and QC Guide

  2026-08-25

  Solanesol is a hydrophobic polyisoprenoid alcohol for biochemical workflows that require controlled preparation of a membrane-associated research compound. It is compatible with DMSO but insoluble in water and ethanol, so it should not be introduced into aqueous or ethanol-only assays without a validated solvent strategy.

• Z-IETD-FMK for Caspase-8 Pathway Studies

  2026-08-24

  Z-IETD-FMK enables targeted interrogation of caspase-8 in apoptosis, immune activation, and death-receptor signaling workflows. Its strongest use-case is mechanistic separation of extrinsic caspase-8 activity from mitochondrial apoptosis, with practical value in T-cell, cancer, and infection-model assays.

450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page